1. Bowers DC, Gargan L, Weprin BE, Muline AF, Elterman RD, Munoz L, Giller CA, Winick NJ (2007) Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma. J Neurosurg 107(1 Suppl Pediatrics):5–10
2. Rossi A, Caracciolo V, Russo G, Reiss K, Giordano A (2008) Medulloblastoma: from molecular pathology to therapy review. Clin Cancer Res 14(4):971–976
3. Sasaki T, Lopes MBS, Hankins GR, Helm GA (2002) Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Acta Neuropathol 104:105–109
4. Li XN, Shu Q, Su JM, Adesina AM, Wong KK, Perlaky L, Antalffy BA, Blaney SM, Lau CC (2007) Differential expression of survivin splice isoforms in medulloblastomas. Neuropathol Appl Neurobiol 33:67–76
5. Liu R, Mitchell DA (2010) Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors. Cancer Immunol Immunother 59:183–193